Asian patients with hepatitis C (HCV) genotype 1 treated with ledipasvir and sofosbuvir (LDV/SOF) experience very high efficacy and improvement of health-related quality of life (HRQL)

Zobair Younossi; Maria Stepanova; Kwang-Hyub Han; Young-Suk Lim; Youn-Jae Lee; Wan-Long Chuang; Jia-Horng Kao; Rong-Nan Chien; Ting-Tsung Chang; Cheng-Yuan Peng

Asian patients with hepatitis C (HCV) genotype 1 treated with ledipasvir and sofosbuvir (LDV/SOF) experience very high efficacy and improvement of health-related quality of life (HRQL)

Zobair Younossi
, Maria Stepanova
, Kwang-Hyub Han
, Young-Suk Lim
, Youn-Jae Lee
, Wan-Long Chuang
, Jia-Horng Kao
, Rong-Nan Chien
, Ting-Tsung Chang
, Cheng-Yuan Peng

中醫學系(含學士班、天然藥物、傳統中醫藥碩士班)

研究成果: 期刊稿件 › 文章 › 同行評審

原文	美式英語
頁（從 - 到）	376-376
期刊	Journal of Gastroenterology and Hepatology
卷	31
出版狀態	已出版 - 2016

UN SDG

此研究成果有助於以下永續發展目標

SDG3 健康與福祉

引用此

Younossi, Z., Stepanova, M., Han, K.-H., Lim, Y.-S., Lee, Y.-J., Chuang, W.-L., Kao, J.-H., Chien, R.-N., Chang, T.-T., & Peng, C.-Y. (2016). Asian patients with hepatitis C (HCV) genotype 1 treated with ledipasvir and sofosbuvir (LDV/SOF) experience very high efficacy and improvement of health-related quality of life (HRQL). Journal of Gastroenterology and Hepatology, 31, 376-376.

@article{8a0613dc36b5494091960c89c658e98a,

title = "Asian patients with hepatitis C (HCV) genotype 1 treated with ledipasvir and sofosbuvir (LDV/SOF) experience very high efficacy and improvement of health-related quality of life (HRQL)",

author = "Zobair Younossi and Maria Stepanova and Kwang-Hyub Han and Young-Suk Lim and Youn-Jae Lee and Wan-Long Chuang and Jia-Horng Kao and Rong-Nan Chien and Ting-Tsung Chang and Cheng-Yuan Peng",

year = "2016",

language = "American English",

volume = "31",

pages = "376--376",

journal = "Journal of Gastroenterology and Hepatology",

issn = "0815-9319",

publisher = "Wiley-Blackwell Publishing Ltd",

}

Younossi, Z, Stepanova, M, Han, K-H, Lim, Y-S, Lee, Y-J, Chuang, W-L, Kao, J-H, Chien, R-N, Chang, T-T & Peng, C-Y 2016, 'Asian patients with hepatitis C (HCV) genotype 1 treated with ledipasvir and sofosbuvir (LDV/SOF) experience very high efficacy and improvement of health-related quality of life (HRQL)', Journal of Gastroenterology and Hepatology, 卷 31, 頁 376-376.

Asian patients with hepatitis C (HCV) genotype 1 treated with ledipasvir and sofosbuvir (LDV/SOF) experience very high efficacy and improvement of health-related quality of life (HRQL). / Younossi, Zobair; Stepanova, Maria; Han, Kwang-Hyub 等.
於: Journal of Gastroenterology and Hepatology, 卷 31, 2016, p. 376-376.

研究成果: 期刊稿件 › 文章 › 同行評審

TY - JOUR

T1 - Asian patients with hepatitis C (HCV) genotype 1 treated with ledipasvir and sofosbuvir (LDV/SOF) experience very high efficacy and improvement of health-related quality of life (HRQL)

AU - Younossi, Zobair

AU - Stepanova, Maria

AU - Han, Kwang-Hyub

AU - Lim, Young-Suk

AU - Lee, Youn-Jae

AU - Chuang, Wan-Long

AU - Kao, Jia-Horng

AU - Chien, Rong-Nan

AU - Chang, Ting-Tsung

AU - Peng, Cheng-Yuan

PY - 2016

Y1 - 2016

M3 - Journal Article

SN - 0815-9319

VL - 31

SP - 376

EP - 376

JO - Journal of Gastroenterology and Hepatology

JF - Journal of Gastroenterology and Hepatology

ER -